Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| FcRn | FCRN-AB001 | Human | HEK293 | Anti-FcRn Antibody (Rozanolixizumab Biosimilar) Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | FcRn |
| HLA-A*03:01 | HLAA0301-HB004 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*03:01 (25–305) AviHis |
| HLA-B*57:01 | HLAB5701-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-B*57:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-B*57:01 (25–362) AviHis |
| KRAS G12D | KRASG12D-HP003 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) His |
| CD8 | CD8-HF002 | Human | HEK293 | Human CD8 beta/CD8B Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | CD8 (22–170) Fc |
| HLA-A*68:01 | HLAA6801-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*68:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*68:01 (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HB003 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&RASL11B (AVVGASGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB015 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| LMP2 | LMP2-HB001 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LMP2 (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HB002 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP009 | Human | HEK293 | Human NY-ESO-1 TCR&CD3 Complex VLP Purity > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 |
| HLA-C*03:04 | HLAC0304-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-C*03:04&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-C*03:04 (25–305) AviHis |
| MAGE-A4 | MAGEA4-HB003 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| MAGE-A4 | MAGEA4-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| KRAS G12D | KRASG12D-HB004 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP005 | Human | HEK293 | Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| Survivin 2B | SURVIVIN2B-HP003 | Human | HEK293 | Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Survivin 2B (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| MAGE-A3 | MAGEA3-HB003 | Human | HEK293 | Biotinylated Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A3 (25–305) AviHis |
| CT83 | CT83-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&KKLC1 (ILNNFPHSI) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CT83 (25–305) AviHis |